Report Code : CVMI24071644 | Published Date : July 16, 2024
The Pain Management Market is experiencing steady growth, driven by the rising prevalence of chronic pain disorders, advancements in pain relief therapies, and increasing demand for non-opioid treatment alternatives. The market, valued at USD XX billion in 2023, is projected to grow at a CAGR of XX% from 2024 to 2031, reaching USD XX billion by 2031.
Pain Management Market Key Insights
Pain management therapies encompass pharmacological treatments, medical devices, and alternative therapies aimed at reducing pain intensity and enhancing quality of life. The market is expanding with the advent of novel pain relief medications, wearable pain management devices, and integrative treatments approaches.
Pain Management Market Growth Drivers
- Rising Cases of Chronic Pain Conditions – The increasing incidence of arthritis, cancer pain, neuropathic pain, and musculoskeletal disorders is driving demand.
- Advancements in Non-Opioid Pain Management Therapies – The push for non-addictive alternatives, such as nerve stimulation, regenerative medicine, and topical analgesics, is accelerating.
- Growing Adoption of Pain Management Devices – The use of TENS (Transcutaneous Electrical Nerve Stimulation) units, neurostimulation devices, and laser therapy has increased expanding.
- The increasing focus on personalized and integrative pain relief approaches, such as acupuncture, physical therapy, and AI-driven pain diagnostics, is gaining traction.
Pain Management Market Regional Trends
- North America leads because of high awareness of the opioid crisis and advanced pain management solutions.
- Europe is expanding with robust regulatory support for alternative pain management therapies.
- The Asia-Pacific region is experiencing rapid growth, fueled by an increasing geriatric population and rising healthcare demands investments.
- Latin America and MEA are emerging markets that are benefiting from the expansion of pain treatment accessibility.
ClearView Market Insights Analysis;
The pain management market is poised for continuous expansion, propelled by technological advancements, an increasing preference for non-opioid treatments, and a heightened focus on personalized pain relief strategies. Companies that invest in innovative drug formulations, AI-driven pain assessment tools, and wearable pain relief devices will lead this evolving sector.
Reasons To Buy
nan
Scope
nan
Key Players
- Pfizer Inc.
- Johnson & Johnson
- GlaxoSmithKline plc
- Eli Lilly and Company
- Abbott Laboratories
Global Pain Management Market Report
- 1. Global Pain Management Market Research Report
- 1.1 Study Objectives
- 1.2 Global Pain Management Market - Overview
- 1.3 Reason to Read This Report
- 1.4 Methodology and Forecast Analysis
- 2.1 Global Pain Management Market Research Report – Detailed Scope and Definitions
- 2.1.1 By Type of Pain
- 2.1.2 By Treatment Type
- 2.1.3 By Pain Source
- 2.1.4 By End User
- 2.1.5 By Region
- 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
- 3.2. Restraints – By Type of Pain, By Treatment Type, By Pain Source, By End User, By Country
- 3.3. Opportunities – By Type of Pain, By Treatment Type, By Pain Source, By End User, By Country
- 3.4. Trends – By Type of Pain, By Treatment Type, By Pain Source, By End User, By Country
- 3.5. PEST Analysis
- 3.6. Porters Five Rule Analysis
- 3.7. Company’s Share Analysis (CSA) by Region or By Country
- 3.8. Global Pain Management Market Research Report – DROTs Impact Analysis
- 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
- 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
- 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.1 Acute Pain
- 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.2 Chronic Pain
- 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.1 Medication-Based (Analgesics
- 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.2 NSAIDs
- 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.3 Opioids)
- 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.4 Non-Medication-Based (Physical Therapy
- 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.5 Acupuncture
- 6.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.6 Chiropractic Care)
- 6.6.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.6.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.6.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.6.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.7 Interventional Procedures (Nerve Blocks
- 6.7.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.7.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.7.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.7.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.8 Epidural Steroid Injections
- 6.8.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.8.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.8.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.8.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.9 Radiofrequency Ablation)
- 6.9.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.9.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.9.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.9.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.1 Neuropathic Pain
- 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.2 Musculoskeletal Pain
- 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.3 Cancer Pain
- 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.4 Postoperative Pain
- 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.5 Migraine and Headache
- 7.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.1 Hospitals
- 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.2 Clinics and Ambulatory Surgical Centers (ASCs)
- 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.3 Homecare Settings
- 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.4 Rehabilitation Centers
- 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.1 North America
- 9.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.2 Europe
- 9.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.3 Asia-Pacific
- 9.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.4 Latin America
- 9.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.5 Middle East & Africa
- 9.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.6 Global Pain Management Market - Opportunity Analysis Index, By Type of Pain, By Treatment Type, By Pain Source, By End User, and Region, 2024 - 2031
- 10.1 By Type of Pain Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 10.1.1 Acute Pain
- 10.1.2 Chronic Pain
- 10.2.1 Medication-Based (Analgesics
- 10.2.2 NSAIDs
- 10.2.3 Opioids)
- 10.2.4 Non-Medication-Based (Physical Therapy
- 10.2.5 Acupuncture
- 10.2.6 Chiropractic Care)
- 10.2.7 Interventional Procedures (Nerve Blocks
- 10.2.8 Epidural Steroid Injections
- 10.2.9 Radiofrequency Ablation)
- 10.3.1 Neuropathic Pain
- 10.3.2 Musculoskeletal Pain
- 10.3.3 Cancer Pain
- 10.3.4 Postoperative Pain
- 10.3.5 Migraine and Headache
- 10.4.1 Hospitals
- 10.4.2 Clinics and Ambulatory Surgical Centers (ASCs)
- 10.4.3 Homecare Settings
- 10.4.4 Rehabilitation Centers
- 10.5.1 United States
- 10.5.2 Canada
10.7 Regional Trends Analysis
10.8 North America Global Pain Management Market Research Report - Company Profiles- 10.8.1 Company 1 (United States)
- 10.8.2 Company 2 (Canada)
- 10.8.3 Company 3 (Canada)
- 11.1 By Type of Pain Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 11.1.1 Acute Pain
- 11.1.2 Chronic Pain
- 11.2.1 Medication-Based (Analgesics
- 11.2.2 NSAIDs
- 11.2.3 Opioids)
- 11.2.4 Non-Medication-Based (Physical Therapy
- 11.2.5 Acupuncture
- 11.2.6 Chiropractic Care)
- 11.2.7 Interventional Procedures (Nerve Blocks
- 11.2.8 Epidural Steroid Injections
- 11.2.9 Radiofrequency Ablation)
- 11.3.1 Neuropathic Pain
- 11.3.2 Musculoskeletal Pain
- 11.3.3 Cancer Pain
- 11.3.4 Postoperative Pain
- 11.3.5 Migraine and Headache
- 11.4.1 Hospitals
- 11.4.2 Clinics and Ambulatory Surgical Centers (ASCs)
- 11.4.3 Homecare Settings
- 11.4.4 Rehabilitation Centers
- 11.5.1 Germany
- 11.5.2 United Kingdom
- 11.5.3 France
- 11.5.4 Spain
- 11.5.5 Italy
- 11.5.6 Russia
- 11.5.7 Netherlands
- 11.5.8 Poland
- 11.5.9 Rest of Europe
11.7 Regional Trends Analysis
11.8 Europe Global Pain Management Market Research Report - Company Profiles- 11.8.1 Company 1 (Germany)
- 11.8.2 Company 2 (United Kingdom)
- 11.8.3 Company 3 (United Kingdom)
- 12.1 By Type of Pain Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 12.1.1 Acute Pain
- 12.1.2 Chronic Pain
- 12.2.1 Medication-Based (Analgesics
- 12.2.2 NSAIDs
- 12.2.3 Opioids)
- 12.2.4 Non-Medication-Based (Physical Therapy
- 12.2.5 Acupuncture
- 12.2.6 Chiropractic Care)
- 12.2.7 Interventional Procedures (Nerve Blocks
- 12.2.8 Epidural Steroid Injections
- 12.2.9 Radiofrequency Ablation)
- 12.3.1 Neuropathic Pain
- 12.3.2 Musculoskeletal Pain
- 12.3.3 Cancer Pain
- 12.3.4 Postoperative Pain
- 12.3.5 Migraine and Headache
- 12.4.1 Hospitals
- 12.4.2 Clinics and Ambulatory Surgical Centers (ASCs)
- 12.4.3 Homecare Settings
- 12.4.4 Rehabilitation Centers
- 12.5.1 China
- 12.5.2 Japan
- 12.5.3 India
- 12.5.4 South Korea
- 12.5.5 Australia & NZ
- 12.5.6 ASEAN
- 12.5.7 Rest of Asia-Pacific
12.7 Regional Trends Analysis
12.8 Asia-Pacific Global Pain Management Market Research Report - Company Profiles- 12.8.1 Company 1 (China)
- 12.8.2 Company 2 (Japan)
- 12.8.3 Company 3 (Japan)
- 13.1 By Type of Pain Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 13.1.1 Acute Pain
- 13.1.2 Chronic Pain
- 13.2.1 Medication-Based (Analgesics
- 13.2.2 NSAIDs
- 13.2.3 Opioids)
- 13.2.4 Non-Medication-Based (Physical Therapy
- 13.2.5 Acupuncture
- 13.2.6 Chiropractic Care)
- 13.2.7 Interventional Procedures (Nerve Blocks
- 13.2.8 Epidural Steroid Injections
- 13.2.9 Radiofrequency Ablation)
- 13.3.1 Neuropathic Pain
- 13.3.2 Musculoskeletal Pain
- 13.3.3 Cancer Pain
- 13.3.4 Postoperative Pain
- 13.3.5 Migraine and Headache
- 13.4.1 Hospitals
- 13.4.2 Clinics and Ambulatory Surgical Centers (ASCs)
- 13.4.3 Homecare Settings
- 13.4.4 Rehabilitation Centers
- 13.5.1 Brazil
- 13.5.2 Mexico
- 13.5.3 Argentina
- 13.5.4 Peru
- 13.5.5 Colombia
- 13.5.6 Rest of Latin America
13.7 Regional Trends Analysis
13.8 Latin America Global Pain Management Market Research Report - Company Profiles- 13.8.1 Company 1 (Brazil)
- 13.8.2 Company 2 (Mexico)
- 13.8.3 Company 3 (Mexico)
- 14.1 By Type of Pain Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 14.1.1 Acute Pain
- 14.1.2 Chronic Pain
- 14.2.1 Medication-Based (Analgesics
- 14.2.2 NSAIDs
- 14.2.3 Opioids)
- 14.2.4 Non-Medication-Based (Physical Therapy
- 14.2.5 Acupuncture
- 14.2.6 Chiropractic Care)
- 14.2.7 Interventional Procedures (Nerve Blocks
- 14.2.8 Epidural Steroid Injections
- 14.2.9 Radiofrequency Ablation)
- 14.3.1 Neuropathic Pain
- 14.3.2 Musculoskeletal Pain
- 14.3.3 Cancer Pain
- 14.3.4 Postoperative Pain
- 14.3.5 Migraine and Headache
- 14.4.1 Hospitals
- 14.4.2 Clinics and Ambulatory Surgical Centers (ASCs)
- 14.4.3 Homecare Settings
- 14.4.4 Rehabilitation Centers
- 14.5.1 Saudi Arabia
- 14.5.2 UAE
- 14.5.3 South Africa
- 14.5.4 Egypt
- 14.5.5 Israel
- 14.5.6 Rest of Middle East and Africa
14.7 Regional Trends Analysis
14.8 Middle East & Africa Global Pain Management Market Research Report - Company Profiles- 14.8.1 Company 1 (Saudi Arabia)
- 14.8.2 Company 2 (UAE)
- 14.8.3 Company 3 (UAE)
- 15.1 Strategic Dashboard of Top Market Players
15.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)- 15.2.1 Pfizer Inc.
- 15.2.2 Johnson & Johnson
- 15.2.3 GlaxoSmithKline plc
- 15.2.4 Eli Lilly and Company
- 15.2.5 Abbott Laboratories
17. Principal Presumptions and Acronyms